Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy.

Bibliographic Details
Main Authors:	Dass, S, Suttie, J, Piechnik, S, Ferreira, V, Holloway, C, Robson, M, Watkins, H, Karamitsos, T, Neubauer, S
Format:	Conference item
Published:	2012

Similar Items

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
by: Dass Sairia, et al.
Published: (2012-02-01)

In Both Hypertrophic And Dilated Cardiomyopathy, Non-contrast T1 Mapping Provides Myocardial Tissue Characterization Beyond That Achieved By Late Gadolinium Enhancement.
by: Dass, S, et al.
Published: (2011)

Myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy.
by: Dass, S, et al.
Published: (2012)

Response to letter regarding article, "myocardial tissue characterization using magnetic resonance noncontrast t1 mapping in hypertrophic and dilated cardiomyopathy".
by: Dass, S, et al.
Published: (2013)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass, S, et al.
Published: (2012)

Cardiac Steatosis Detected in Hypertrophic Cardiomyopathy, Dilated Cardiomyopathy and Aortic Stenosis
by: Suttie, J, et al.
Published: (2011)

Derangement of cardiac energy metabolism is acutely exacerbated during exercise in hypertrophic cardiomyopathy, independent of hypertrophy or late gadolinium burden
by: Dass Sairia, et al.
Published: (2012-02-01)

ACUTE DERANGEMENT OF CARDIAC ENERGY METABOLISM AND OXYGENATION DURING STRESS IN HYPERTROPHIC CARDIOMYOPATHY-A POTENTIAL MECHANISM FOR SUDDEN CARDIAC DEATH
by: Dass, S, et al.
Published: (2012)

Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy.
by: Karamitsos, T, et al.
Published: (2013)

Is the Myocardium Oxygen Deprived in Non Ischemic Heart Failure?
by: Dass, S, et al.
Published: (2013)

Patients with Dilated Cardiomyopathy (DCM) have appropriate myocardial oxygenation response to vasodilator stress
by: Dass Sairia, et al.
Published: (2013-01-01)

Exercise acutely exacerbates derangement of cardiac energy metabolism in hypertrophic cardiomyopathy, a 31 phosphorus magnetic resonance study at 3 Telsa
by: Dass, S, et al.
Published: (2015)

Patients with hypertrophic cardiomyopathy (HCM) and HCM gene carriers have attenuated myocardial oxygenation response to vasodilator stress - a potential mechanism for sudden cardiac death.
by: Dass, S, et al.
Published: (2012)

Adenosine stress and rest T1 mapping can differentiate between ischemic, infarcted, remote, and normal myocardium without the need for gadolinium contrast agents.
by: Liu, A, et al.
Published: (2015)

The Prognostic Value of Late Gadolinium Enhancement CMR in Nonischemic Cardiomyopathies
by: Karamitsos, T, et al.
Published: (2013)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.
by: Karamitsos, T, et al.
Published: (2013)

Further refining risk in hypertrophic cardiomyopathy with late gadolinium enhancement by CMR
by: Kramer, C, et al.
Published: (2018)

The role of cardiac energy metabolism and during stress in hypertrophic and dilated cardiomyopathy.
by: Dass, S
Published: (2012)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
by: Watkins, H
Published: (2003)

Obesity-related ventricular remodelling is exacerbated in dilated and hypertrophic cardiomyopathy
by: Rayner, JJ, et al.
Published: (2020)

Exercise training improves cardiac function, quality of life and exercise capacity in patients with dilated cardiomyopathy
by: Karamitsos Theodoros, et al.
Published: (2011-02-01)

Exercise training in dilated cardiomyopathy improves rest and stress cardiac function without changes in cardiac high energy phosphate metabolism.
by: Holloway, C, et al.
Published: (2012)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
by: Hudsmith, L, et al.
Published: (2006)

Differential Expression of microRNAs in Hypertrophied Myocardium and Their Relationship to Late Gadolinium Enhancement, Left Ventricular Hypertrophy and Remodeling in Hypertrophic Cardiomyopathy
by: Chen Zhang, et al.
Published: (2022-08-01)

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents
by: Ferreira, V, et al.
Published: (2014)

Native T1-mapping detects the location, extent and patterns of acute myocarditis without the need for gadolinium contrast agents.
by: Ferreira, V, et al.
Published: (2014)

Toward replacing late gadolinium enhancement with artificial intelligence virtual native enhancement for gadolinium-free cardiovascular magnetic resonance tissue characterization in hypertrophic cardiomyopathy
by: Zhang, Q, et al.
Published: (2021)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
by: Di Bella Gianluca, et al.
Published: (2010-04-01)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
by: Ariga, R, et al.
Published: (2018)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
by: Ariga, R, et al.
Published: (2019)

The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies topical collection on cardiac PET, CT, and MRI
by: Karamitsos, T, et al.
Published: (2013)

Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy
by: Gaston A. Rodriguez-Granillo, et al.
Published: (2016-01-01)

Native T1 time and extracellular volume fraction in differentiation of normal myocardium from non-ischemic dilated and hypertrophic cardiomyopathy myocardium: A systematic review and meta-analysis
by: Shintaro Minegishi, et al.
Published: (2019-12-01)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
by: Hamza El Hadi, et al.
Published: (2023-02-01)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
by: Seitaro Nomura, et al.
Published: (2023-03-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
by: Enrica Chiti, et al.
Published: (2021-09-01)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
by: Gehan Abd El-Rahman El-Zarea, et al.
Published: (2016-02-01)

Prognostic Significance of Late Gadolinium Enhancement in Children with Dilated Cardiomyopathy
by: Zhongqin Zhou, MD, et al.
Published: (2024-01-01)

Clinical significance of late gadolinium enhancement in pediatric patients with hypertrophic cardiomyopathy
by: Smith Brandon M, et al.
Published: (2013-01-01)

Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
by: Lopes Mário G, et al.
Published: (2010-01-01)